SOCS3 antibody (full length)
Quick Overview for SOCS3 antibody (full length) (ABIN94467)
Target
See all SOCS3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length
-
Purpose
- Anti-SOCS3 Purified
-
Cross-Reactivity (Details)
- Human
-
Characteristics
- The antibody SO1 reacts with SOCS3, an intracellular cytokine signaling inhibitor.
-
Purification
- Purified by protein-A affinity chromatography.
-
Purity
- > 95 % (by SDS-PAGE)
-
Immunogen
- Full-length SOCS3 protein.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Western blotting: Positive control: HeLa human cervix carcinoma cell line, reducing conditions.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do not freeze
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C. Do not freeze.
-
-
-
: "Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion." in: Endocrine-related cancer, Vol. 14, Issue 4, pp. 1007-19, (2007) (PubMed).
-
-
- SOCS3 (Suppressor of Cytokine Signaling 3 (SOCS3))
-
Alternative Name
- SOCS3
-
Background
- Suppressor of cytokine signaling 3,SOCS3 (suppressor of cytokine signaling 3), also known as CIS3 (cytokine-inducible SH2 protein 3) is a negative regulator of particular cytokine signaling pathways. SOCS3 is induced by a variety of cytokines and other stimuli, such as erythropoietin, leptin and lipopolysaccharides and inhibits tyrosinkinase activity of JAK kinases, or e.g. JNK phosphorylation. SOCS3 modulates cytokine-mediated and neoplastic-proliferative responses and is involved also in maintaining leukocytes in quiescent state until antigen stimulation.,SOCS-3, CIS3, SSI3
-
Gene ID
- 9021
-
UniProt
- Q6FI39
-
Pathways
- JAK-STAT Signaling, Response to Growth Hormone Stimulus, Hepatitis C
Target
-